Total submissions: 10
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001081719 | SCV000547481 | benign | Fanconi anemia | 2024-01-22 | criteria provided, single submitter | clinical testing | |
Genetic Services Laboratory, |
RCV000502866 | SCV000597139 | uncertain significance | not specified | 2016-11-29 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000464063 | SCV001150768 | likely benign | not provided | 2024-05-01 | criteria provided, single submitter | clinical testing | SLX4: BP4 |
Illumina Laboratory Services, |
RCV001121832 | SCV001280485 | uncertain significance | Fanconi anemia complementation group P | 2017-04-28 | criteria provided, single submitter | clinical testing | This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. However, the evidence from the literature, in combination with allele frequency data from public databases where available, was not sufficient to rule this variant in or out of causing disease. Therefore, this variant is classified as a variant of unknown significance. |
Baylor Genetics | RCV001121832 | SCV001482655 | uncertain significance | Fanconi anemia complementation group P | 2020-11-23 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Institute for Clinical Genetics, |
RCV000464063 | SCV002010279 | uncertain significance | not provided | 2021-11-03 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV001081719 | SCV002529300 | likely benign | Fanconi anemia | 2021-02-13 | criteria provided, single submitter | curation | |
Gene |
RCV000464063 | SCV002586578 | uncertain significance | not provided | 2022-10-17 | criteria provided, single submitter | clinical testing | Observed in individuals with breast or ovarian cancer, but also in unaffected controls (de Garibay 2013, Bakker 2013, Shah 2013, Song 2020); Published functional studies demonstrate cell growth similar to wild-type following exposure to Mitomycin C (Bakker 2013); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23211700, 22911665, 23840564, 28678401, 32546565, 34426522) |
Prevention |
RCV003912802 | SCV004730813 | likely benign | SLX4-related disorder | 2020-01-27 | criteria provided, single submitter | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |
Leiden Open Variation Database | RCV000502866 | SCV001364629 | likely benign | not specified | 2012-08-31 | no assertion criteria provided | curation | Curator: Arleen D. Auerbach. Submitter to LOVD: Janine Bakker. |